Produto adicionado correctamente ao carrinho.

discount label
H-VWLSVIWM-OH
Ver 3D

Biosynth logo

H-VWLSVIWM-OH

Ref. 3D-PP48564

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Entrega estimada em Estados Unidos, Sexta-feira 27 de Dezembro de 2024

Informação sobre produto

Nome:
H-VWLSVIWM-OH
Descrição:

Peptide H-VWLSVIWM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VWLSVIWM-OH include the following: Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice Z Qi, G Li, H Hu , C Yang, X Zhang, Q Leng - Journal of , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01024-14 The IL-1R/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model Z Ma, J Liu, W Wu, E Zhang , X Zhang, Q Li - Cellular & molecular , 2017 - nature.comhttps://www.nature.com/articles/cmi201743 Recombinant Covalently Closed Circular Y Gao, K Lan, Q Deng, QL Zhang, Y Xie, D Yu, X Zhang - J. Virol, 2014 - academia.eduhttps://www.academia.edu/download/44061139/Recombinant_Covalently_Closed_Circular_H20160324-30626-1qn6viw.pdf Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model Y Bu, K Zhao, Z Xu, Y Zheng, R Hua, C Wu, C Zhu - Virologica Sinica, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1995820X23000482 HBsAg-specific CD8+ T cells as an indispensable trigger to induce murine hepatocellular carcinoma X Hao , Y Chen, L Bai , H Wei, R Sun - Cellular & molecular , 2021 - nature.comhttps://www.nature.com/articles/s41423-019-0330-1 A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X TH Kingl - S and Core Specific T Cells in Mice and Activates , 2014 - academia.eduhttps://www.academia.edu/download/89859031/f142b96de8e26e56244e549779a6a66d9a01.pdf A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to TH King, CB Kemmler , Z Guo, D Mann, Y Lu - PloS one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0101904 WHOLE RECOMBINANT YEAST THERAPEUTIC VACCINE GENERATES HBV X, S, AND CORE ANTIGEN-SPECIFIC RESPONSES IN MURINE AND HUMAN TH King, AJ Gehring , A Bertoletti , ZZ Ho - Journal of , 2013 - globeimmune.comhttp://globeimmune.com/wp-content/uploads/2012/04/King_EASL_2013_HBV_4-25-13.pdf Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity S Zeissig , K Murata, L Sweet, J Publicover, Z Hu - Nature medicine, 2012 - nature.comhttps://www.nature.com/articles/nm.2811 Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen R Schirmbeck, W Böhm, N Fissolo - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324125 Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T R Schirmbeck, P Riedl, R Zurbriggen - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/171/10/5198/1831 Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants R Schirmbeck, N Dikopoulos, M Kwissa - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324403 Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice P Bochtler, C Wahl, R Schirmbeck - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/12/8307/74015 Regulatory mechanisms in immune responses P Bochtler - 2016 - oparu.uni-ulm.dehttps://oparu.uni-ulm.de/items/3327a214-8225-43b3-9212-68bdb90d21dc Novel peptide-based vaccines efficiently prime murine"help"-independent CD8+ T cell responses in the liver N Dikopoulos, P Riedl, R Schirmbeck, J Reimann - Hepatology, 2004 - Wiley Online Libraryhttps://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.20330 Specific, functional effector/memory CD8+ T cells are found in the liver post-vaccination N Dikopoulos, I Jomantaite, R Schirmbeck - Journal of , 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168827803004690 Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells N Dikopoulos, A Bertoletti , A Kröger - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/1/99/72273 NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner MO Diniz, A Schurich, SK Chinnakannan - Science Translational , 2022 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.abi4670 A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice MA Cobleigh, X Wei , MD Robek - Journal of virology, 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02111-12 Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice L Zong, H Peng, C Sun , F Li , M Zheng, Y Chen - Nature , 2019 - nature.comhttps://www.nature.com/articles/s41467-018-08096-8 Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses L Cao , C Wu, H Shi, Z Gong, E Zhang, H Wang - Journal of , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01123-14 Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model G Li, Y Zhu, D Shao, H Chang, X Zhang, D Zhou - , 2018 - Wiley Online Libraryhttps://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29406 A mouse model for HBV immunotolerance and immunotherapy D Yang, L Liu , D Zhu, H Peng, L Su, YX Fu - Cellular & molecular , 2014 - nature.comhttps://www.nature.com/articles/cmi201343 Evaluation of antiviral-passive-active immunization ("œsandwich") therapeutic strategy for functional cure of chronic hepatitis B in mice B Shi, Y Wu, C Wang, X Li, F Yu, B Wang, Z Yang - , 2019 - thelancet.comhttps://www.thelancet.com/article/S2352-3964(19)30713-3/fulltext

Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:

Propriedades químicas

MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:

Informação sobre riscos

Número ONU:
EQ:
Classe:
Frases H:
Frases P:
Proibido de voar:
Informação sobre riscos:
Grupo de Embalagem:
LQ:

Consulta técnica sobre: 3D-PP48564 H-VWLSVIWM-OH

Por favor, utilize o carrinho para solicitar um orçamento ou uma encomenda

Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.

* Campos obrigatórios
Bem-vindo à CymitQuimica!Usamos cookies para melhorar sua visita. Não incluímos publicidade.

Consulte a nossa Política de Cookies para mais detalhes ou ajuste suas preferências em "Configurar".